FORMA Signs Collaboration Agreement With Cubist

FORMA Therapeutics of Cambridge said that it has signed a collaboration agreement with Cubist Pharmaceuticals Inc. to leverage FORMA’s chemistry platform to discover novel antibacterial compounds for development by Cubist.
boston.com